scholarly journals Artificial Intelligence in Current Diabetes Management and Prediction

2021 ◽  
Vol 21 (12) ◽  
Author(s):  
Akihiro Nomura ◽  
Masahiro Noguchi ◽  
Mitsuhiro Kometani ◽  
Kenji Furukawa ◽  
Takashi Yoneda
Keyword(s):  
Artificial Intelligence ◽  
Medical Devices ◽  
Prediction Models ◽  
Diabetes Management ◽  
Predictive Performance ◽  
Management Tool ◽  
Dramatic Improvement ◽  
The Us ◽  
Diabetes Prediction ◽  
Computational Resources

Abstract Purpose of Review Artificial intelligence (AI) can make advanced inferences based on a large amount of data. The mainstream technologies of the AI boom in 2021 are machine learning (ML) and deep learning, which have made significant progress due to the increase in computational resources accompanied by the dramatic improvement in computer performance. In this review, we introduce AI/ML-based medical devices and prediction models regarding diabetes. Recent Findings In the field of diabetes, several AI-/ML-based medical devices and regarding automatic retinal screening, clinical diagnosis support, and patient self-management tool have already been approved by the US Food and Drug Administration. As for new-onset diabetes prediction using ML methods, its performance is not superior to conventional risk stratification models that use statistical approaches so far. Summary Despite the current situation, it is expected that the predictive performance of AI will soon be maximized by a large amount of organized data and abundant computational resources, which will contribute to a dramatic improvement in the accuracy of disease prediction models for diabetes.

scholarly journals The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database

2020 ◽  
Vol 3 (1) ◽  
Author(s):  
Stan Benjamens ◽  
Pranavsingh Dhunnoo ◽  
Bertalan Meskó
Keyword(s):  
Artificial Intelligence ◽  
Medical Devices ◽  
De Novo ◽  
Online Database ◽  
Medical Technologies ◽  
The Us ◽  
Open Access Database ◽  
Regulatory Bodies ◽  
Premarket Approval ◽  
Insight Into

Abstract At the beginning of the artificial intelligence (AI)/machine learning (ML) era, the expectations are high, and experts foresee that AI/ML shows potential for diagnosing, managing and treating a wide variety of medical conditions. However, the obstacles for implementation of AI/ML in daily clinical practice are numerous, especially regarding the regulation of these technologies. Therefore, we provide an insight into the currently available AI/ML-based medical devices and algorithms that have been approved by the US Food & Drugs Administration (FDA). We aimed to raise awareness of the importance of regulatory bodies, clearly stating whether a medical device is AI/ML based or not. Cross-checking and validating all approvals, we identified 64 AI/ML based, FDA approved medical devices and algorithms. Out of those, only 29 (45%) mentioned any AI/ML-related expressions in the official FDA announcement. The majority (85.9%) was approved by the FDA with a 510(k) clearance, while 8 (12.5%) received de novo pathway clearance and one (1.6%) premarket approval (PMA) clearance. Most of these technologies, notably 30 (46.9%), 16 (25.0%), and 10 (15.6%) were developed for the fields of Radiology, Cardiology and Internal Medicine/General Practice respectively. We have launched the first comprehensive and open access database of strictly AI/ML-based medical technologies that have been approved by the FDA. The database will be constantly updated.

Regulating Medical Devices in the United States

2020 ◽  
Author(s):  
Patricia J. Zettler ◽  
Erika Lietzan
Keyword(s):  
United States ◽  
Medical Device ◽  
Medical Devices ◽  
Complete Information ◽  
The United States ◽  
Risk Level ◽  
Management Tools ◽  
Medical Technologies ◽  
The Us ◽  
Medical Device Regulation

This chapter assesses the regulation of medical devices in the United States. The goal of the US regulatory framework governing medical devices is the same as the goal of the framework governing medicines. US law aims to ensure that medical devices are safe and effective for their intended uses; that they become available for patients promptly; and that manufacturers provide truthful, non-misleading, and complete information about the products. US medical device law is different from US medicines law in many ways, however, perhaps most notably because most marketed devices do not require pre-market approval. The chapter explores how the US Food and Drug Administration (FDA) seeks to accomplish its mission with respect to medical devicecough its implementation of its medical device authorities. It starts by explaining what constitutes a medical device and how the FDA classifies medical devices by risk level. The chapter then discusses how medical devices reach the market, the FDA's risk management tools, and the rules and incentives for innovation and competition. It concludes by exploring case studies of innovative medical technologies that challenge the traditional US regulatory scheme to consider the future of medical device regulation.

Automated Insulin Delivery Systems: Today, Tomorrow and User Requirements

2021 ◽  
pp. 193229682110299
Author(s):  
Marga Giménez ◽  
Ignacio Conget ◽  
Nick Oliver
Keyword(s):  
Lived Experience ◽  
Diabetes Management ◽  
Real Life ◽  
Insulin Delivery ◽  
Qualitative Assessment ◽  
Management Tool ◽  
Diabetes Distress ◽  
Glycemic Targets

Automated insulin delivery (AID) is the most recent advance in type 1 diabetes (T1D) management. It has the potential to achieve glycemic targets without disabling hypoglycemia, to improve quality of life and reduce diabetes distress and burden associated with self-management. Several AID systems are currently licensed for use by people with T1D in Europe, United States, and the rest of the world. Despite AID becoming a reality in routine clinical practice over the last few years, the commercially hybrid AID and other systems, are still far from a fully optimized automated diabetes management tool. Implementation of AID systems requires education and support of healthcare professionals taking care of people with T1D, as well as users and their families. There is much to do to increase usability, portability, convenience and to reduce the burden associated with the use of the systems. Co-design, involvement of people with lived experience of T1D and robust qualitative assessment is critical to improving the real-world use of AID systems, especially for those who may have greater need. In addition to this, information regarding the psychosocial impact of the use of AID systems in real life is needed. The first commercially available AID systems are not the end of the development journey but are the first step in learning how to optimally automate insulin delivery in a way that is equitably accessible and effective for people living with T1D.

scholarly journals Development of Machine Learning Models to Predict Probabilities and Types of Stroke at Prehospital Stage: the Japan Urgent Stroke Triage Score Using Machine Learning (JUST-ML)

2021 ◽  
Author(s):  
Kazutaka Uchida ◽  
Junichi Kouno ◽  
Shinichi Yoshimura ◽  
Norito Kinjo ◽  
Fumihiro Sakakibara ◽  
...  
Keyword(s):  
Machine Learning ◽  
Logistic Regression ◽  
Random Forests ◽  
Prediction Models ◽  
Characteristic Curve ◽  
Predictive Performance ◽  
Vessel Occlusion ◽  
Predictive Values ◽  
Training Cohort ◽  
Sensitivity Specificity

AbstractIn conjunction with recent advancements in machine learning (ML), such technologies have been applied in various fields owing to their high predictive performance. We tried to develop prehospital stroke scale with ML. We conducted multi-center retrospective and prospective cohort study. The training cohort had eight centers in Japan from June 2015 to March 2018, and the test cohort had 13 centers from April 2019 to March 2020. We use the three different ML algorithms (logistic regression, random forests, XGBoost) to develop models. Main outcomes were large vessel occlusion (LVO), intracranial hemorrhage (ICH), subarachnoid hemorrhage (SAH), and cerebral infarction (CI) other than LVO. The predictive abilities were validated in the test cohort with accuracy, positive predictive value, sensitivity, specificity, area under the receiver operating characteristic curve (AUC), and F score. The training cohort included 3178 patients with 337 LVO, 487 ICH, 131 SAH, and 676 CI cases, and the test cohort included 3127 patients with 183 LVO, 372 ICH, 90 SAH, and 577 CI cases. The overall accuracies were 0.65, and the positive predictive values, sensitivities, specificities, AUCs, and F scores were stable in the test cohort. The classification abilities were also fair for all ML models. The AUCs for LVO of logistic regression, random forests, and XGBoost were 0.89, 0.89, and 0.88, respectively, in the test cohort, and these values were higher than the previously reported prediction models for LVO. The ML models developed to predict the probability and types of stroke at the prehospital stage had superior predictive abilities.

scholarly journals Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Espen Jimenez-Solem ◽  
Tonny S. Petersen ◽  
Casper Hansen ◽  
Christian Hansen ◽  
Christina Lioma ◽  
...  
Keyword(s):  
Prediction Models ◽  
Severe Disease ◽  
External Validation ◽  
Area Under The Curve ◽  
Predictive Performance ◽  
Mortality Prediction ◽  
Icu Admission ◽  
Risk Of Death ◽  
Online Risk ◽  
The United Kingdom

AbstractPatients with severe COVID-19 have overwhelmed healthcare systems worldwide. We hypothesized that machine learning (ML) models could be used to predict risks at different stages of management and thereby provide insights into drivers and prognostic markers of disease progression and death. From a cohort of approx. 2.6 million citizens in Denmark, SARS-CoV-2 PCR tests were performed on subjects suspected for COVID-19 disease; 3944 cases had at least one positive test and were subjected to further analysis. SARS-CoV-2 positive cases from the United Kingdom Biobank was used for external validation. The ML models predicted the risk of death (Receiver Operation Characteristics—Area Under the Curve, ROC-AUC) of 0.906 at diagnosis, 0.818, at hospital admission and 0.721 at Intensive Care Unit (ICU) admission. Similar metrics were achieved for predicted risks of hospital and ICU admission and use of mechanical ventilation. Common risk factors, included age, body mass index and hypertension, although the top risk features shifted towards markers of shock and organ dysfunction in ICU patients. The external validation indicated fair predictive performance for mortality prediction, but suboptimal performance for predicting ICU admission. ML may be used to identify drivers of progression to more severe disease and for prognostication patients in patients with COVID-19. We provide access to an online risk calculator based on these findings.

scholarly journals Prediction Models for Public Health Containment Measures on COVID-19 Using Artificial Intelligence and Machine Learning: A Systematic Review

2021 ◽  
Vol 18 (9) ◽  
pp. 4499
Author(s):  
Anil Babu Payedimarri ◽  
Diego Concina ◽  
Luigi Portinale ◽  
Massimo Canonico ◽  
Deborah Seys ◽  
...  
Keyword(s):  
Public Health ◽  
Artificial Intelligence ◽  
Machine Learning ◽  
Systematic Review ◽  
Public Transportation ◽  
Prediction Models ◽  
Positive Impact ◽  
Health Interventions ◽  
Public Health Interventions ◽  
Commercial Activities

Artificial Intelligence (AI) and Machine Learning (ML) have expanded their utilization in different fields of medicine. During the SARS-CoV-2 outbreak, AI and ML were also applied for the evaluation and/or implementation of public health interventions aimed to flatten the epidemiological curve. This systematic review aims to evaluate the effectiveness of the use of AI and ML when applied to public health interventions to contain the spread of SARS-CoV-2. Our findings showed that quarantine should be the best strategy for containing COVID-19. Nationwide lockdown also showed positive impact, whereas social distancing should be considered to be effective only in combination with other interventions including the closure of schools and commercial activities and the limitation of public transportation. Our findings also showed that all the interventions should be initiated early in the pandemic and continued for a sustained period. Despite the study limitation, we concluded that AI and ML could be of help for policy makers to define the strategies for containing the COVID-19 pandemic.

scholarly journals Quantitative Longitudinal Predictions of Alzheimer’s Disease by Multi-Modal Predictive Learning

2021 ◽  
Vol 79 (4) ◽  
pp. 1533-1546
Author(s):  
Mithilesh Prakash ◽  
Mahmoud Abdelaziz ◽  
Linda Zhang ◽  
Bryan A. Strange ◽  
Jussi Tohka ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Prediction Models ◽  
Predictive Performance ◽  
Absolute Error ◽  
Disease Stage ◽  
Disease Assessment ◽  
Disease Category ◽  
Modal Data ◽  
Predictive Learning

Background: Quantitatively predicting the progression of Alzheimer’s disease (AD) in an individual on a continuous scale, such as the Alzheimer’s Disease Assessment Scale-cognitive (ADAS-cog) scores, is informative for a personalized approach as opposed to qualitatively classifying the individual into a broad disease category. Objective: To evaluate the hypothesis that the multi-modal data and predictive learning models can be employed for future predicting ADAS-cog scores. Methods: Unimodal and multi-modal regression models were trained on baseline data comprised of demographics, neuroimaging, and cerebrospinal fluid based markers, and genetic factors to predict future ADAS-cog scores for 12, 24, and 36 months. We subjected the prediction models to repeated cross-validation and assessed the resulting mean absolute error (MAE) and cross-validated correlation (ρ) of the model. Results: Prediction models trained on multi-modal data outperformed the models trained on single modal data in predicting future ADAS-cog scores (MAE12, 24 & 36 months= 4.1, 4.5, and 5.0, ρ12, 24 & 36 months= 0.88, 0.82, and 0.75). Including baseline ADAS-cog scores to prediction models improved predictive performance (MAE12, 24 & 36 months= 3.5, 3.7, and 4.6, ρ12, 24 & 36 months= 0.89, 0.87, and 0.80). Conclusion: Future ADAS-cog scores were predicted which could aid clinicians in identifying those at greater risk of decline and apply interventions at an earlier disease stage and inform likely future disease progression in individuals enrolled in AD clinical trials.

Prediction Models for Truck Accidents at Freeway Ramps in Washington State Using Regression and Artificial Intelligence Techniques

1998 ◽  
Vol 1635 (1) ◽  
pp. 30-36 ◽  
Author(s):  
Wael H. Awad ◽  
Bruce N. Janson
Keyword(s):  
Artificial Intelligence ◽  
Neural Networks ◽  
Linear Regression ◽  
Prediction Models ◽  
Washington State ◽  
Training Data ◽  
Coefficient Of Determination ◽  
Training Process ◽  
Truck Accidents ◽  
High Level

Three different modeling approaches were applied to explain truck accidents at interchanges in Washington State during a 27-month period. Three models were developed for each ramp type including linear regression, neural networks, and a hybrid system using fuzzy logic and neural networks. The study showed that linear regression was able to predict accident frequencies that fell within one standard deviation from the overall mean of the dependent variable. However, the coefficient of determination was very low in all cases. The other two artificial intelligence (AI) approaches showed a high level of performance in identifying different patterns of accidents in the training data and presented a better fit when compared to the regression model. However, the ability of these AI models to predict test data that were not included in the training process showed unsatisfactory results.

Artificial intelligence based prediction models: sales forecasting application in automotive aftermarket

2021 ◽  
pp. 1-13
Author(s):  
Mert Girayhan Türkbayrağí ◽  
Elif Dogu ◽  
Y. Esra Albayrak
Keyword(s):  
Artificial Intelligence ◽  
Computational Intelligence ◽  
Prediction Models ◽  
Predictive Analytics ◽  
Demand Characteristic ◽  
Product Portfolio ◽  
Ann Model ◽  
Nonlinear Relationships ◽  
Relationship Of ◽  
Automotive Aftermarket

Automotive aftermarket industry is possessed of a wide product portfolio range which is in the 4th rank by its worldwide trade volume. The demand characteristic of automotive aftermarket parts is volatile and uncertain. Nevertheless, the cause-and-effect relationship of automotive aftermarket industry has not been defined obviously heretofore. These conditions bring automotive aftermarket sales forecasting into a challenging process. This paper is composed to determine the relevant external factors for automotive aftermarket sales based on expert reviews and to propose a sales forecasting model for automotive aftermarket industry. Since computational intelligence techniques yield a framework to focus on predictive analytics and prescriptive analytics, an artificial neural network model constructed for Turkey automotive aftermarket industry. Artificial intelligence is a subset of computational intelligence that focused on problems which have complex and nonlinear relationships. The data which have complex and nonlinear relationships could be modelled successfully even though incomplete data in case of implementation of appropriate model. The proposed ANN model for sales forecast is compared with multiple linear regression and revealed a higher prediction performance.

Sign in / Sign up

Export Citation Format

Share Document